Biotechnology and Development ApS: Financial statements 2018
CVR: 33870639
Source: annual report 2018, Danish Business Authority
01/07/2017 – 30/06/2018
Biotechnology and Development ApS (CVR 33870639) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 36,448 and a net result of DKK 5,553 compared with DKK -2,821 the year before. That is an increase of 46.2% compared with the year before. Equity in the 2018 report amounted to DKK 20,104. The solvency ratio was 14.2%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 36,448
- Profit/Loss
- DKK 5,553
- Equity
- DKK 20,104
- Total Assets
- DKK 141,709
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 36 t. | 6 t. | 20 t. | 1 |
| 2017 | - | 25 t. | -3 t. | 15 t. | - |
| 2016 | - | 32 t. | 13 t. | 17 t. | - |
| 2015 | - | 14 t. | 10 t. | 4 t. | - |
| 2014 | - | -12 t. | -9 t. | -6 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationAbout Biotechnology and Development ApS
Biotechnology and Development ApS is a Danish company of the type Anpartsselskab based in Silkeborg, founded in 2011. The company is registered under the industry Engroshandel med andre råvarer og halvfabrikata. The management consists of Karl Erik Molbech. The company is owned by KLMC Holding ApS. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK 282,184 and a net result of DKK -1,709 compared with DKK 66,166 the year before. Equity in the 2025 report amounted to DKK 105,217.